Herbal extracts and phytochemicals: plant secondary metabolites and the enhancement of human brain function - PubMed (original) (raw)

Review

Herbal extracts and phytochemicals: plant secondary metabolites and the enhancement of human brain function

David O Kennedy et al. Adv Nutr. 2011 Jan.

Abstract

Humans consume a wide range of foods, drugs, and dietary supplements that are derived from plants and which modify the functioning of the central nervous sytem (CNS). The psychoactive properties of these substances are attributable to the presence of plant secondary metabolites, chemicals that are not required for the immediate survival of the plant but which are synthesized to increase the fitness of the plant to survive by allowing it to interact with its environment, including pathogens and herbivorous and symbiotic insects. In many cases, the effects of these phytochemicals on the human CNS might be linked either to their ecological roles in the life of the plant or to molecular and biochemical similarities in the biology of plants and higher animals. This review assesses the current evidence for the efficacy of a range of readily available plant-based extracts and chemicals that may improve brain function and which have attracted sufficient research in this regard to reach a conclusion as to their potential effectiveness as nootropics. Many of these candidate phytochemicals/extracts can be grouped by the chemical nature of their potentially active secondary metabolite constituents into alkaloids (caffeine, nicotine), terpenes (ginkgo, ginseng, valerian, Melissa officinalis, sage), and phenolic compounds (curcumin, resveratrol, epigallocatechin-3-gallate, Hypericum perforatum, soy isoflavones). They are discussed in terms of how an increased understanding of the relationship between their ecological roles and CNS effects might further the field of natural, phytochemical drug discovery.

PubMed Disclaimer

Conflict of interest statement

Author disclosures: D. Kennedy and E. Wightman, no conflicts of interest.

Figures

Figure 1

Figure 1

Structures of the alkaloids caffeine and nicotine.

Figure 2

Figure 2

Structures of selected terpenes, including the monoterpenes 1,8-cineole and geraniol, the sesquiterpene, valerenic acid, the diterpene, ginkgolide A, and the triterpene, ginsenoside Rg1.

Figure 3

Figure 3

Structures of selected phenolic compounds.

Similar articles

Cited by

References

    1. Newman DJ, Cragg GM. Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007;70:461–77 - PubMed
    1. Mukherjee PK, Kumar V, Mal M, Houghton PJ. Acetylcholinesterase inhibitors from plants. Phytomedicine. 2007;14:289–300 - PubMed
    1. National Institute of Clinical Excellence NICE technology appraisal guidance. Donepezil, galantamine, rivastigmine (review) and memantine for the treatment of Alzheimer’s disease (amended). London: National Institute of Clinical Excellence; 2009
    1. Bent S. Herbal medicine in the United States: review of efficacy, safety, and regulation. Grand rounds at University of California, San Francisco Medical Center. J Gen Intern Med. 2008;23:854–9 - PMC - PubMed
    1. Pimentel D, Andow DA. Pest-management and pesticide impacts. Insect Sci Appl. 1984;5:141–9

Publication types

MeSH terms

Substances

LinkOut - more resources